Alkeon Capital Management - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 396 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.80 and the average weighting 0.3%.

Quarter-by-quarter ownership
Alkeon Capital Management ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$55,621,191
-4.6%
458,845
-9.8%
0.10%
-2.9%
Q2 2023$58,272,929
-40.7%
508,845
-28.6%
0.10%
-52.8%
Q1 2023$98,249,910
+12.6%
712,834
+5.8%
0.22%
-35.9%
Q4 2022$87,286,643
-35.9%
673,612
-45.3%
0.34%
-23.4%
Q3 2022$136,119,000
+57.0%
1,231,396
+6.5%
0.44%
+88.8%
Q2 2022$86,684,000
-5.6%
1,156,396
-1.6%
0.23%
+26.6%
Q1 2022$91,853,000
-6.8%
1,175,796
+7.4%
0.18%
+0.5%
Q4 2021$98,605,000
+1098.1%
1,095,000
+1130.3%
0.18%
+1207.1%
Q3 2021$8,230,000
+218.9%
89,000
+345.0%
0.01%
+40.0%
Q4 2019$2,581,00020,0000.01%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Sonic Fund II, L.P. 112,689$14,541,00014.93%
Casdin Capital, LLC 670,000$86,457,0007.95%
Logos Global Management LP 226,002$29,163,0007.19%
Avoro Capital Advisors LLC 1,760,000$227,110,0006.67%
Camber Capital Management LP 600,000$77,424,0003.94%
STANSBERRY ASSET MANAGEMENT, LLC 71,133$9,179,0003.74%
Eventide Asset Management 996,000$128,524,0003.62%
CADIAN CAPITAL MANAGEMENT, LP 550,000$70,972,0003.14%
RTW INVESTMENTS, LP 605,762$78,168,0002.95%
Consonance Capital Management LP 356,145$45,957,0002.80%
View complete list of SAREPTA THERAPEUTICS INC shareholders